Does ALTEPLASE Cause Dysarthria? 65 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Dysarthria have been filed in association with ALTEPLASE (Activase). This represents 0.5% of all adverse event reports for ALTEPLASE.
65
Reports of Dysarthria with ALTEPLASE
0.5%
of all ALTEPLASE reports
3
Deaths
28
Hospitalizations
How Dangerous Is Dysarthria From ALTEPLASE?
Of the 65 reports, 3 (4.6%) resulted in death, 28 (43.1%) required hospitalization, and 7 (10.8%) were considered life-threatening.
Is Dysarthria Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALTEPLASE. However, 65 reports have been filed with the FAERS database.
What Other Side Effects Does ALTEPLASE Cause?
No adverse event (2,456)
Off label use (1,752)
Gingival bleeding (1,018)
Cerebral haemorrhage (819)
Death (818)
Haemorrhage intracranial (615)
Angioedema (603)
Haemorrhage (536)
Drug ineffective (524)
Haemorrhagic transformation stroke (496)
What Other Drugs Cause Dysarthria?
OLANZAPINE (900)
QUETIAPINE (669)
PREGABALIN (618)
AMLODIPINE (553)
GABAPENTIN (548)
METFORMIN (540)
METHOTREXATE (536)
DIAZEPAM (512)
ASPIRIN (495)
LORAZEPAM (483)
Which ALTEPLASE Alternatives Have Lower Dysarthria Risk?
ALTEPLASE vs ALTERNARIA ALTERNATA
ALTEPLASE vs ALTHIAZIDE
ALTEPLASE vs ALTHIAZIDE\SPIRONOLACTONE
ALTEPLASE vs ALUMINUM
ALTEPLASE vs ALUMINUM HYDROXIDE